Replies to post #64511 on Cytodyn Inc (CYDY)

[JPG77]

Gee, I wonder who that could be...and now they're desperately trying to cover.

somebody is selling stock very aggressively

[justdafactss]

Yes, aggressive selling indeed this may be the culprit-

In April 2019 the Company delivered to Samsung a purchase order for $33 million worth of process validation and technology transfer services related to the manufacture of leronlimab, with payments by the Company scheduled to be made throughout calendar 2020. Under the Samsung Agreement, the purchase order is binding and the Company is obligated to pay the full amount of the purchase order. Under the terms of the Samsung Agreement, the Company is obligated to make specified minimum purchases of leronlimab from Samsung pursuant to forecasted requirements which the Company will provide to Samsung. The first forecast will be delivered to Samsung by March 31, 2020. Thereafter, the Company must provide Samsung with a rolling quarterly forecast setting forth the total quantity of commercial grade leronlimab that the Company expects to require in the following years. The Company estimates that initial ramp-up costs to manufacture commercial grade leronlimab at scale could total approximately $60 million, with approximately $30 million payable over the course of calendar 2020, and approximately $30 million payable in the first quarter of 2021. Thereafter, the Company will pay Samsung per 15,000L batch according to the pricing terms specified in the Samsung Agreement

https://www.sec.gov/Archives/edgar/data/1175680/000119312520004683/d855842d10q.htm

Looks like time probably caught up with NP in so far as nobody to sell leronlimab to at this point in time.

Note all the NUMEROUS press release touts during the month of March and the March 31, 2020 timeframe.